# Protalix BioTherapeutics, Inc.: Form 8-K, filed Feb 16, 2017

- Company: [Protalix BioTherapeutics, Inc.](/companies/plx.md) (CIK 1006281)
- Form: 8-K
- Filed: 2017-02-16
- Accepted by EDGAR: Feb 16, 2017, 16:31 ET
- Period: 2017-02-16
- Accession: 0001144204-17-009587
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1006281/000114420417009587/v459846_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1006281/000114420417009587/

## Items reported

- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1006281/000114420417009587/v459846_8k.htm

Filed Feb 16, 2017.
Source: SEC EDGAR, the filing index for accession 0001144204-17-009587. Last ingested by Listed: Nov 10, 2026, 16:48 ET. No prices; not investment advice.
